Certican

Certican (Everolimus) is an oral medication used to prevent organ rejection after transplants. It works by suppressing the immune system to help the body accept the new organ.

Certican is primarily used to prevent rejection of transplanted organs, such as kidneys, hearts, or livers. It is often prescribed to patients who have undergone organ transplantation to help their bodies accept the new organ. The medication works by suppressing the immune system's response to the transplanted organ, reducing the risk of rejection.

Common effects of Certican may include headaches, nausea, diarrhea, and fatigue. Some users may also experience swelling in the limbs or difficulty breathing. These effects can vary in severity and may not affect everyone who takes the medication.

Certican should be handled with care and stored as directed. It is important to follow the prescribed dosage and not to stop taking the medication without consulting a healthcare provider. Patients should also be aware of potential interactions with other medications and should inform their healthcare provider of all medications they are taking.

Certican may interact with certain medications, including those that are metabolized by the liver's cytochrome P450 system. This includes some antibiotics, antifungals, and anticonvulsants. It is also important to avoid grapefruit and grapefruit juice, as they can increase the levels of Certican in the body.